144 related articles for article (PubMed ID: 37273023)
41. Posterior-First Two-Stage Approach to En Bloc Resection of Locally Recurrent Rectal Cancer Involving the Pelvic Sidewall.
Sakata S; Karim SM; Mathis KL; Kelley SR; Rose PS; Dozois EJ
Dis Colon Rectum; 2021 Aug; 64(8):e465-e470. PubMed ID: 34214058
[TBL] [Abstract][Full Text] [Related]
42. Anatomical approaches in locally advanced and recurrent pelvic malignancy.
Collins D; Jones R; Griffiths B
Eur J Surg Oncol; 2022 Nov; 48(11):2258-2262. PubMed ID: 35086682
[TBL] [Abstract][Full Text] [Related]
43. Intra-operative radiation therapy after a total lateral extended infralevator exenteration for recurrent cervical cancer.
Manzour N; Vázquez-Vicente D; Carriles I; Boria F; Chacon E; Chiva L
Int J Gynecol Cancer; 2021 Aug; 31(8):1188-1189. PubMed ID: 34031133
[No Abstract] [Full Text] [Related]
44. Clinical outcome of pelvic exenteration in patients with advanced or recurrent uterine cervical cancer.
Tanaka S; Nagase S; Kaiho-Sakuma M; Nagai T; Kurosawa H; Toyoshima M; Tokunaga H; Otsuki T; Utsunomiya H; Takano T; Niikura H; Ito K; Yaegashi N
Int J Clin Oncol; 2014 Feb; 19(1):133-8. PubMed ID: 23404487
[TBL] [Abstract][Full Text] [Related]
45. [Application of fascial space priority approach for pelvic exenteration].
Yang HJ; Sun Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Mar; 26(3):290-294. PubMed ID: 36925130
[TBL] [Abstract][Full Text] [Related]
46. Validation of MRI and Surgical Decision Making to Predict a Complete Resection in Pelvic Exenteration for Recurrent Rectal Cancer.
Brown WE; Koh CE; Badgery-Parker T; Solomon MJ
Dis Colon Rectum; 2017 Feb; 60(2):144-151. PubMed ID: 28059910
[TBL] [Abstract][Full Text] [Related]
47. Management of recurrent cervical cancer: a review of the literature.
Peiretti M; Zapardiel I; Zanagnolo V; Landoni F; Morrow CP; Maggioni A
Surg Oncol; 2012 Jun; 21(2):e59-66. PubMed ID: 22244884
[TBL] [Abstract][Full Text] [Related]
48. [Laparoscopic pelvic exenteration for cervical cancer relapse: preliminary study].
Uzan C; Rouzier R; Castaigne D; Pomel C
J Gynecol Obstet Biol Reprod (Paris); 2006 Apr; 35(2):136-45. PubMed ID: 16575359
[TBL] [Abstract][Full Text] [Related]
49. [Analysis on risk factors of the degree of radical resection and prognosis of patients with locally recurrent rectal cancer].
Zhang JL; Wu T; Chen GW; Wang PY; Jiang Y; Tang JQ; Wu YC; Pan YS; Liu YC; Wan YL; Wang X
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 May; 23(5):472-479. PubMed ID: 32842427
[No Abstract] [Full Text] [Related]
50. [Difficulties and challenges of pelvic exenteration in locally advanced rectal cancer].
Gu J; Gao QK
Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Mar; 26(3):215-221. PubMed ID: 36925120
[TBL] [Abstract][Full Text] [Related]
51. Resectability rates of previously irradiated recurrent cervical cancer (PIRCC) treated with pelvic exenteration: is still the clinical involvement of the pelvis wall a real contraindication? a twenty-year experience.
Jurado M; Alcázar JL; Martinez-Monge R
Gynecol Oncol; 2010 Jan; 116(1):38-43. PubMed ID: 19878978
[TBL] [Abstract][Full Text] [Related]
52. Management of recurrent cervical cancer.
Dreyer G; Snyman LC; Mouton A; Lindeque BG
Best Pract Res Clin Obstet Gynaecol; 2005 Aug; 19(4):631-44. PubMed ID: 16150396
[TBL] [Abstract][Full Text] [Related]
53. Prognostic factors for curative pelvic exenterations in patients with recurrent uterine cervical or vaginal cancer.
Sardain H; Lavoué V; Laviolle B; Henno S; Foucher F; Levêque J
Int J Gynecol Cancer; 2014 Nov; 24(9):1679-85. PubMed ID: 25254565
[TBL] [Abstract][Full Text] [Related]
54. Disease-free survival after robotic-assisted laparoscopic total pelvic exenteration for recurrent cervical adenocarcinoma: A case report.
Yang Q; Tang J; Xiao L
Medicine (Baltimore); 2018 Jul; 97(30):e11611. PubMed ID: 30045297
[TBL] [Abstract][Full Text] [Related]
55. Anterior pelvic exenteration and laterally extended pelvic resection: a step by step procedure.
Daix M; Angeles MA; Leray H; Vergriete K; Martinez A; Ferron G
Int J Gynecol Cancer; 2022 Jan; 32(1):107-108. PubMed ID: 34711666
[No Abstract] [Full Text] [Related]
56. Indications and long-term clinical outcomes in 282 patients with pelvic exenteration for advanced or recurrent cervical cancer.
Schmidt AM; Imesch P; Fink D; Egger H
Gynecol Oncol; 2012 Jun; 125(3):604-9. PubMed ID: 22406639
[TBL] [Abstract][Full Text] [Related]
57. Curative pelvic exenteration for recurrent cervical carcinoma in the era of concurrent chemotherapy and radiation therapy. A systematic review.
Sardain H; Lavoue V; Redpath M; Bertheuil N; Foucher F; Levêque J
Eur J Surg Oncol; 2015 Aug; 41(8):975-85. PubMed ID: 25922209
[TBL] [Abstract][Full Text] [Related]
58. Laparoscopic Resection of Pelvic Sidewall Recurrent Cervical Cancer: Feasibility Does Not Always Equate with Clinical Indication.
Ramirez PT
J Minim Invasive Gynecol; 2017; 24(6):881. PubMed ID: 28642026
[No Abstract] [Full Text] [Related]
59. The evolution of oncovascular pelvic surgery: A historical perspective.
Rajendran S; Nguyen CL; Brown KGM; Solomon MJ
Eur J Surg Oncol; 2023 Jul; 49(7):1314-1316. PubMed ID: 36690534
[TBL] [Abstract][Full Text] [Related]
60. New developments in the surgical therapy of cervical carcinoma.
Dornhöfer N; Höckel M
Ann N Y Acad Sci; 2008 Sep; 1138():233-52. PubMed ID: 18837903
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
